日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Design and synthesis of non-hydroxamate lipophilic inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): in silico, in vitro and antibacterial studies

1-脱氧-d-木酮糖 5-磷酸还原异构酶 (DXR) 非羟肟酸亲脂性抑制剂的设计和合成:计算机模拟、体外和抗菌研究

Sharyu Kesharwani, Eeba, Mukesh Tandi, Nisheeth Agarwal, Sandeep Sundriyal

Quantitative Proteomics Reveals that Hsp90 Inhibition Dynamically Regulates Global Protein Synthesis in Leishmania mexicana

定量蛋白质组学揭示 Hsp90 抑制动态调节墨西哥利什曼原虫的整体蛋白质合成

Karunakaran Kalesh, Sandeep Sundriyal, Hirunika Perera, Steven L Cobb, Paul W Denny

Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket

基于噻吩并嘧啶酮的 Sirtuin-2 (SIRT2) 选择性抑制剂与配体诱导的选择性口袋结合

Sandeep Sundriyal, Sébastien Moniot, Zimam Mahmud, Shang Yao, Paolo Di Fruscia, Christopher R Reynolds, David T Dexter, Michael J E Sternberg, Eric W-F Lam, Clemens Steegborn, Matthew J Fuchter

Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti- Plasmodium activity

组蛋白赖氨酸甲基转移酶结构活性关系,允许分离 G9a 抑制和抗疟原虫活性

Sandeep Sundriyal, Patty B Chen, Alexandra S Lubin, Gregor A Lueg, Fengling Li, Andrew J P White, Nicholas A Malmquist, Masoud Vedadi, Artur Scherf, Matthew J Fuchter

Development of diaminoquinazoline histone lysine methyltransferase inhibitors as potent blood-stage antimalarial compounds

二氨基喹唑啉组蛋白赖氨酸甲基转移酶抑制剂作为强效血液阶段抗疟化合物的开发

Sandeep Sundriyal #, Nicholas A Malmquist #, Joachim Caron, Scott Blundell, Feng Liu, Xin Chen, Nitipol Srimongkolpithak, Jian Jin, Susan A Charman, Artur Scherf, Matthew J Fuchter